A study in mice conducted by researchers at the Sloan Kettering Institute identifies sugar as a key regulator of a cancer-causing protein. The discovery could lead to a new treatment strategy.
LITTLE ROCK, Ark.--(BUSINESS WIRE)--Kuria Therapeutics, a pharmaceutical company developing novel ophthalmic and dermal therapeutics, is pleased to announce it has completed a pre-Investigational New ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback